Why the study?
Does aspirin prophylaxis reduce fatal and nonfatal myocardial infarction in primary prevention?
Population
Primary prevention cohort (Physicians' Health Study)
Design
Editorial
Loading...
This letter highlights a striking 88% reduction in expected cardiovascular mortality in the aspirin component of the Physicians' Health Study.
Does aspirin prophylaxis reduce fatal and nonfatal myocardial infarction in primary prevention?
This letter highlights a striking 88% reduction in expected cardiovascular mortality in the aspirin component of the Physicians' Health Study.
A 1988 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: